MIR548D2

Across TCGA pan-cancer cohorts, MIR548D2 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated MIR548D2 data layer.

The strongest signal is observed in thymoma (THYM), where higher MIR548D2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR548D2 expression acts as an unfavorable survival marker, although some lineages such as HNSC and ESCA show a favorable association.

THYM, THCA, and HNSC are the cancer types where MIR548D2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Tertile	All	0.502	0.913	.002	66	view →
THCA	OS	Tertile	III,IV	0.301	0.907	.003	57	view →
HNSC	DFS	Tertile	All	0.932	0.593	.011	39	view →
UCS	DFS	Tertile	All	0.136	0.523	.034	18	view →
ESCA	DFS	Tertile	III,IV	0.717	0.377	.049	9	view →
SARC	DFS	Tertile	All	0.098	0.591	.010	9	view →
SKCM	OS	Tertile	All	0.556	0.328	.033	6	view →
UCEC	DFS	Tertile	All	0.388	0.659	.035	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

MIR548D2–THYM (OS)

Open the THYM breakdown →